- Teerlink, John;
- Filippatos, G;
- Teerlink, JR;
- Farmakis, D;
- Cotter, G;
- Davison, BA;
- Felker, GM;
- Greenberg, BH;
- Hua, T;
- Ponikowski, P;
- Severin, T
Aims Serelaxin is effective in relieving dyspnoea and improving multiple outcomes in acute heart failure (AHF). Many AHF patients have preserved ejection fraction (HFpEF). Given the lack of evidence-based therapies in this population, we evaluated the effe
